Clovis Oncology, Inc. Convertible Debt, Noncurrent
Clovis Oncology, Inc. had Convertible Debt, Noncurrent of $437.80 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2022-11-09
- 2022-06-30: Convertible Debt, Noncurrent $437.80M.
- 2022-03-31: Convertible Debt, Noncurrent $437.28M.
- 2021-12-31: Convertible Debt, Noncurrent $436.77M.
- 2021-09-30: Convertible Debt, Noncurrent $436.26M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2022-06-30 | $437.80M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $437.28M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $436.77M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $436.26M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $435.76M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $435.35M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $434.85M 10-K · filed 2022-02-24 |
| 2020-09-30 | $505.28M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $504.68M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $524.90M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $644.75M 10-K · filed 2021-02-25 |
| 2019-09-30 | $644.10M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $576.76M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $576.00M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $575.47M 10-K · filed 2020-02-26 |
| 2018-09-30 | $574.83M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $574.34M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $282.73M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $282.41M 10-K · filed 2019-02-28 |
| 2017-09-30 | $282.08M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $281.76M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $281.44M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $281.13M 10-K · filed 2018-02-27 |
| 2015-12-31 | $279.88M 10-K · filed 2017-02-23 |